P45 HIGH-DOSE CARFILZOMIB ACHIEVES SUPERIOR ANTI-TUMOR ACTIVITY OVER LOW-DOSE AND RECAPTURES RESPONSE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RESISTANT TO LOW-DOSE CARFILZOMIB BY CO-INHIBITING THE B2 AND B1 PROTEASOME SUBUNITS

Autor: X. Zhou, A. Besse, J. Peter, M. J. Steinhardt, C. Vogt, S. Nerreter, E. Teufel, E. Stanojkovska, X. Xiao, H. Hornburger, L. Haertle, M. Mendez Lopez, U. Munawar, A. Riedel, S. Han, E. Maurits, H. S. Overkleeft, B. Florea, H. Einsele, K. M. Kortüm, C. Driessen, L. Besse, L. Rasche
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: HemaSphere, Vol 7, Iss S2, Pp 35-36 (2023)
Druh dokumentu: article
ISSN: 2572-9241
DOI: 10.1097/01.HS9.0000936308.40864.64
Databáze: Directory of Open Access Journals